Enterprise Value (EV)
Current Enterprise Value (EV)
Pfizer Inc., current enterprise value calculation
|Current share price (P)|
|No. shares of common stock outstanding|
|US$ in millions|
|Common equity (market value)1|
|Add: Preferred stock, no par value, at stated value (per books)|
|Add: Equity attributable to noncontrolling interests (per books)|
|Add: Short-term borrowings, including current portion of long-term debt (per books)|
|Add: Long-term debt, excluding current portion (per books)|
|Total equity and debt|
|Less: Cash and cash equivalents|
|Less: Short-term investments|
|Enterprise value (EV)|
Based on: 10-K (filing date: 2020-02-27).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
Historical Enterprise Value (EV)
Pfizer Inc., EV calculation
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Pfizer Inc.’s Annual Report.
3 2019 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
|EV||Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.||Pfizer Inc.’s EV increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.|